Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating benign prostatic hyperplasia

A prostatic hyperplasia and composition technology, applied in the field of drugs for the treatment of benign prostatic hyperplasia, can solve problems such as dysuria, affect the quality of life of patients, and have a lot of medicinal taste, and achieve the effects of improving quality of life, reducing residual urine volume, and stabilizing the curative effect

Active Publication Date: 2014-05-14
南通市乐悦实业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] BPH can cause dysuria, incessant leaching, frequent urination, increased nocturia, etc. Further development can lead to complications such as severe urinary tract infection, bladder stones, hematuria, urinary retention, renal failure, inguinal hernia, etc., seriously affecting the patient quality of life
[0004] There are many treatment methods for BPH, but there are various methods for the treatment of BPH at home and abroad, which encounter the following thorny problems: surgical treatment is traumatic, has many complications, and the elderly have poor tolerance to surgery and anesthesia
Drugs that reduce the size of the prostate, such as finasteride (Proscar), can reduce the size of the prostate, but are more expensive (9 yuan / day), and the effect is slow (starts in March); it can also cause low libido , impotence and other side effects
[0005] Although some Chinese patent medicines for the treatment of benign prostatic hyperplasia have been researched at present, they still cannot meet the needs of patients, and the composition of their prescriptions is relatively complicated, with more medicinal flavors, higher prices, and poor curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating benign prostatic hyperplasia
  • Medicine composition for treating benign prostatic hyperplasia
  • Medicine composition for treating benign prostatic hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials: 9 g of Rhizoma Chuanxiong, and 9 g of honeycomb.

[0029] The above-mentioned medicinal raw materials are prepared into soft capsules, and the preparation method is as follows:

[0030] (1) Take Rhizoma Chuanxiong according to the proportion of the formula, reflux extract with 10 times the volume of 85% ethanol for 3 times, each time for 1.5h, filter the extract, combine the filtrate, concentrate under reduced pressure to obtain the extract, dissolve in water, filter with suction, and filtrate Pass through a macroporous resin column (the volume ratio of extract and resin is 1:20), elute with water first, discard the water eluate, then elute with 30% ethanol, combine the 30% ethanol eluate, Ethanol was recovered under reduced pressure, dried in vacuo to obtain the extract of Rhizoma Chuanxiong.

[0031] (2) Take hive ...

Embodiment 2

[0034] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials: 3 g of Rhizoma Chuanxiong and 3 g of Honeycomb.

[0035] The above-mentioned medicinal raw materials are prepared into powder injection, and the preparation method is as follows:

[0036] (1) Take Rhizoma Chuanxiong according to the proportion of the formula, reflux extract with 8 times the volume of 50% ethanol for 3 times, each time for 1.5h, filter the extract, combine the filtrate, concentrate under reduced pressure to obtain the extract, dissolve in water, filter with suction, and filtrate Pass through a macroporous resin column (the volume ratio of extract and resin is 1:15), elute with water first, discard the water eluate, then elute with 30% ethanol, combine the 30% ethanol eluate, Ethanol was recovered under reduced pressure, dried in vacuo to obtain the extract of Rhizoma Chuanxiong.

[0037] (2) Take the ...

Embodiment 3

[0040] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials: 15 g of Rhizoma Chuanxiong and 15 g of honeycomb.

[0041] The above medicinal raw materials are prepared into capsules, and the preparation method is as follows:

[0042] (1) Take Ligusticum chuanxiong according to the proportion of the formula, reflux extract with 10 times the volume of 95% ethanol for 3 times, each time for 1.5h, filter the extract, combine the filtrate, concentrate under reduced pressure to obtain the extract, dissolve in water, filter with suction, and filtrate Pass through a macroporous resin column (the volume ratio of extract and resin is 1:20), elute with water first, discard the water eluate, then elute with 30% ethanol, combine the 30% ethanol eluate, Ethanol was recovered under reduced pressure, dried in vacuo to obtain the extract of Rhizoma Chuanxiong.

[0043] (2) Take the medicinal ma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating benign prostatic hyperplasia (BPH), comprising Ligusticum wallichii and nidus vespae. The medicine composition disclosed herein can rapidly alleviate the clinical symptoms of BPH patients, and can reduce the prostate volume, and the price is low, and there is no side effect.

Description

technical field [0001] The invention relates to a medicine for treating benign prostatic hyperplasia, in particular to a pharmaceutical composition for treating benign prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia (BPH) is a common disease among elderly men, and its incidence increases with age. According to reports, the population of elderly men over 60 years old in my country has reached 150 million, and the incidence rate is 60%. Those who suffer from BPH before the age of 60, currently about 100 million people in my country suffer from BPH. [0003] BPH can cause dysuria, incessant leaching, frequent urination, increased nocturia, etc. Further development can lead to complications such as severe urinary tract infection, bladder stones, hematuria, urinary retention, renal failure, inguinal hernia, etc., seriously affecting the patient's quality of life. [0004] There are many treatment methods for BPH, but the various methods for treating BP...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/236A61P13/08A61K35/64
Inventor 李文军张太君张玲成建国
Owner 南通市乐悦实业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com